Christopher J. Scoggins
Equibles does not estimate personal net worth.
Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.
Get ABT alertsAbout Christopher J. Scoggins
The proxy statement of Abbott Laboratories reports total compensation of $6,601,667 for Christopher J. Scoggins in fiscal 2025, including a base salary of $859,502. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Robert E. Funck, Jr. (CFO) and 7 others.
Affiliation history
-
Abbott Laboratories (ABT)
Proxy statement
Current
Company network
Leadership on record at Abbott Laboratories
- Robert B. Ford CEO, Chairman, Board Member
- Philip P. Boudreau CFO
- Robert E. Funck, Jr. CFO
- Claire Babineaux-Fontenot Board Member
- Daniel J. Starks Board Member
- Darren W. McDew Board Member
- John G. Stratton Board Member
- Kevin Conroy Board Member
- Michael F. Roman Board Member
- Michael G. O’Grady Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Abbott Laboratories (ABT) | Executive Vice President, Diabetes Care | $859,502 | $6,601,667 |
Recent activity
No call appearances or filed executive changes recorded yet.